Cefazolin Sodium

7 trials 3 recruiting JAnti-infectives

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

3 Recruiting

2 Completed trials

6 Sponsors

6 Countries

Phase III

Phase IV

Phase III: 5 Phase IV: 2

Indications tested

Antibiotic level therapeutic 1 Retinitis pigmentosa 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 2 Amsterdam UMC Stichting 1 Assistance Publique Hopitaux De Paris 1 Janssen - Cilag International 1 Rigshospitalet 1 UZ Leuven 1

All trials

7 total

Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter ran… Pending

2024-518018-22-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
Rapid Oral Switch in Infectious Endocarditis, the ROSIE study Recruiting

2025-524484-20-00 Phase IV 1 country UZ Leuven
Local Antibiotics for Women Undergoing Breast Reconstruction Surgery with Implants Recruiting

2024-517672-38-00 Phase III 1 country Rigshospitalet
Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting

2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Long Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defec… Ended

2024-511411-25-00 Phase III 6 countries Janssen Cilag International
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial) Ended

2024-515398-90-01 Phase III 1 country Stichting Amsterdam UMC

Showing 1–7 of 7 trials

← All drugs A–Z